Top 10 Wholesale Suppliers Of Phenylephrine 5 Mg Tablets in India
Updated Dokcare Lifesciences Team 7 min read
Table of contents
- Top 10 Wholesale Suppliers of Phenylephrine 5 Mg Tablets in India — A B2B Sourcing Guide
- Understanding the Formulation — What Phenylephrine 5mg Actually Does in This Combination
- The four-component cold relief formulation contains:
- Market Snapshot — Why This Combination Works B2B
- Top 10 Wholesale Suppliers of Phenylephrine 5mg Cold Tablets in India
- What Actually Separates These Suppliers — A Closer Look
- The Dokcare Lifesciences Advantage — NNOR-P
- Choosing the Right Wholesale Supplier — What to Verify Before You Commit
- FAQs
- What is Phenylephrine 5mg used for in this combination tablet?
- Is this tablet prescription-only in India?
- What is the standard MRP range for this cold combination tablet in India?
- Can I get this under my own brand label from Dokcare Lifesciences?
- Why choose a Chandigarh/Panchkula-based supplier for this formulation?
Top 10 Wholesale Suppliers of Phenylephrine 5 Mg Tablets in India — A B2B Sourcing Guide
Published by Dokcare Lifesciences | General & Cold Medicine Division
Phenylephrine 5 mg, usually in combination with Paracetamol, Diphenhydramine, and Caffeine, is right at the heart of that prescription flow. It’s a classic quad combination that addresses the full cold symptom spectrum in a single tablet, and for that reason, it remains one of the most in-demand SKUs across general physician territories, PCD franchise portfolios, and third-party manufacturing pipelines across India.
For anyone building a cold medicine range, identifying the right wholesale supplier for this formulation is one of the first — and most important — decisions you’ll make. The market has a lot of players. The challenge isn’t finding one; it’s finding one that consistently delivers quality, packaging, documentation, and supply reliability together. That’s what this guide is here to help you with.
Understanding the Formulation — What Phenylephrine 5mg Actually Does in This Combination
Before we get into who supplies it, let’s be clear about what this combination achieves, because understanding the molecule helps you explain it to your prescriber network better — and that’s where franchise businesses are built.
The four-component cold relief formulation contains:
- Phenylephrine HCl 5mg — Alpha-1 adrenergic agonist; acts as a nasal decongestant by constricting swollen blood vessels in the nasal passages, relieving stuffy nose and sinus pressure
- Paracetamol 500mg — Trusted analgesic and antipyretic; reduces fever, body ache, and headache associated with cold and flu
- Diphenhydramine HCl 25mg — First-generation antihistamine; controls runny nose, sneezing, and watery eyes; mild sedative effect supports night-time symptom relief
- Caffeine 30mg — CNS stimulant that enhances the analgesic effect of Paracetamol and counteracts the drowsiness caused by Diphenhydramine
Together, the combination of tablet addresses nasal congestion, fever, headache, body ache, sneezing, and runny nose — essentially the full OPD cold presentation — in a single tablet, twice daily. For a GP managing 60-80 patients on a busy OPD day, a single prescription covering all symptoms is genuinely preferred over four separate prescriptions.
That clinical efficiency is what drives the commercial demand for this SKU, and what makes it a reliable addition to any general medicine or GP-focused franchise portfolio.
Market Snapshot — Why This Combination Works B2B
The cold and respiratory OTC/Rx segment in India runs year-round, but it peaks during seasonal transitions — which in India means there are at least three to four major demand spikes annually. For franchise distributors:
- GPs are your primary prescribers — they account for the bulk of cold symptom consults across Tier 2 and Tier 3 markets
- Retail chemist pull-through is strong because cold tablets have fast rotation — no shelf-aging risk
- The combination format commands better MRP than standalone Paracetamol — giving you healthy margin on a high-volume product
- Private labelling opportunity is significant — this is one of the most popular molecules for loan licence branding in the general medicine segment
Top 10 Wholesale Suppliers of Phenylephrine 5mg Cold Tablets in India
The following companies are active wholesale suppliers and manufacturers of the Paracetamol + Phenylephrine 5mg + Diphenhydramine + Caffeine combination in India, actively offering PCD franchise and third-party manufacturing:
| Company | Location | Brand / Product | Wholesale Price (10×10 Box) | GMP Status |
|---|---|---|---|---|
| Dokcare Lifesciences | Chandigarh, HR | NNOR-P | Contact for Rate | GMP Certified |
| Cafoli Lifecare Pvt. Ltd. | Ludhiana, PB | Paraplom Cold | On Request | WHO-GMP |
| Aitne Lifesciences (Chemross) | Chandigarh, CH | Atfrost-Plus | ₹ 120/box | ISO Certified |
| Healthgate Pvt. Ltd. | Panchkula, HR | Rhinosoft | ₹ 599/box (10×10) | GMP Certified |
| Medhexa Pharma | Panchkula, HR | Mexacof-DMR | On Request | GMP Certified |
| Bendic Health Care Pvt. Ltd. | Panchkula, HR | Bycold | On Request | GMP Certified |
| World Pharma | — | — | ₹ 35/strip (10 tab) | Certified |
| Vridam Healthcare Pvt. Ltd. | Maharashtra | Vricold | ₹ 47.14/strip | GMP Certified |
| Abiba Pharmacia | Punjab | Vocol Tablets | MRP ₹1,500 (25×10) | GMP Certified |
| Jackson Laboratories Pvt. Ltd. | Punjab | Cold Free | On Request | WHO-GMP |
Prices are indicative, sourced from publicly available IndiaMart and TradeIndia listings. Actual B2B/franchise rates vary by order volume, territory, and packaging specification. Always request a formal quotation.
What Actually Separates These Suppliers — A Closer Look
Not all these companies operate at the same scale or with the same quality systems, and as a franchise partner or private label buyer, the price per box is only one dimension of your sourcing decision.
Cafoli Lifecare Pvt. Ltd. (Ludhiana) has built a strong reputation in the PCD space for the Phenylephrine-based cold combination specifically. Their Paraplom Cold Tablet carries WHO-GMP certification and is positioned actively for franchise expansion across North India. For tricity-based franchise partners in Punjab, Haryana, and HP, their supply logistics are efficient.
Aitne Lifesciences out of Chandigarh’s Mani Majra industrial zone offers this combination at an aggressive ₹120/box for the 10×10 pack — making them one of the more accessible options for new franchise entrants looking for a low entry-cost cold tablet. ISO certification is in place; they’ve been active since 2017.
Healthgate Pvt. Ltd. (Panchkula) is positioned at the higher end of the PCD price band at ₹599 for a 10×10 box — reflecting their packaging quality and product documentation standard. They’re a PCD franchise company active since 2021 and ideal for franchise partners targeting upper-tier retail accounts.
Abiba Pharmacia’s Vocol Tablets come in a 25×10 format (250 tablets per carton) at MRP ₹1,500 — catering to bulk wholesale and hospital supply buyers rather than small-volume franchise entrants.
Jackson Laboratories and Medhexa Pharma are among the top-rated suppliers on IndiaMart for this specific combination, consistently receiving franchise enquiries across India. Both companies offer formal pricing on verified B2B enquiry.
The Dokcare Lifesciences Advantage — NNOR-P
We want to be transparent about where we stand in this list. Dokcare Lifesciences‘ NNOR-P is our entry in this formulation category — Paracetamol 500mg + Phenylephrine HCl 5mg + Diphenhydramine HCl 25mg + Caffeine 30mg in a standard 10×10 tablet format.
What NNOR-P offers your franchise business that a commodity cold tablet doesn’t:
- Quality-consistent manufacturing — GMP facility, validated batch process, no API sourcing shortcuts
- Clean batch documentation — COA, stability data, and full regulatory paperwork with every dispatch
- Packaging built for retail shelf appeal — strip design and secondary box that looks credible in front of a GP or retail chemist
- Part of a broader Dokcare cold and general medicine portfolio — meaning you can consolidate your general medicine franchise under one supplier, which simplifies your ordering and logistics
For franchise partners covering GP-heavy territories in Tier 2 and Tier 3 markets, NNOR-P functions as a reliable volume anchor in the general medicine segment. It’s not positioned as the cheapest option — it’s positioned as the product your prescribers will keep asking for.
👉 Explore NNOR-P on our product page
Choosing the Right Wholesale Supplier — What to Verify Before You Commit
Whether you’re evaluating Dokcare or any other supplier on this list, here’s the minimum verification checklist before signing a franchise or placing a bulk order:
| Verification Point | Why It Matters |
|---|---|
| GMP / WHO-GMP Certificate | Confirms the manufacturing facility meets pharma-grade standards |
| CDSCO product approval | Ensures the combination formulation is legally approved for sale |
| Batch COA (Certificate of Analysis) | Verifies potency, purity, and quality of each specific batch |
| Stability data | Confirms shelf-life validity in Indian climate conditions |
| Strip / Alu-Alu packaging options | Humidity-barrier packaging matters in coastal and monsoon zones |
| MOQ and lead time in writing | Protects you from supply gaps during demand peaks |
| Private label / loan licence flexibility | Essential if you’re building your own brand identity |

FAQs
What is Phenylephrine 5mg used for in this combination tablet?
It acts as a nasal decongestant — shrinks swollen blood vessels in the nasal lining to relieve stuffiness and sinus congestion. It’s the “unblock the nose” ingredient in the combination.
Is this tablet prescription-only in India?
Yes. The combination falls under Schedule H (due to the antihistamine and decongestant components) and requires a doctor’s prescription for retail dispensing.
What is the standard MRP range for this cold combination tablet in India?
Typically ₹35–65 per strip of 10 tablets at retail, depending on brand positioning and market tier. B2B/franchise prices are negotiated separately with manufacturers.
Can I get this under my own brand label from Dokcare Lifesciences?
Yes — NNOR-P is available for third-party and loan licence manufacturing with full private label customization. Reach out to our team to discuss batch sizes and documentation.
Why choose a Chandigarh/Panchkula-based supplier for this formulation?
The tricity region has dense pharmaceutical manufacturing infrastructure, fast logistics to North, Central, and East India franchise territories, and competitive pricing due to cluster economics. It’s one of the most efficient B2B sourcing hubs for general medicine SKUs.
- #and Caffeine
- #Diphenhydramine
- #Dokcare Lifesciences
- #franchise business for phenylephrine 5 mg
- #list of top 10 supplier of phenylephrine 5 mg
- #NNOR-P
- #Paracetamol
- #PCD franchise portfolios
- #pcd pharma franchise for phenylephrine 5 mg
- #third-party manufacturing of Phenylephrine 5 Mg Tablets
- #Top 10 Wholesale Suppliers Of Phenylephrine 5 Mg Tablets in India
- #wholesale suppliers and manufacturers of phenylephrine 5 mg
- #Wholesale Suppliers of Phenylephrine
- #Wholesale Suppliers of Phenylephrine 5 Mg Tablets in India
Start your PCD pharma business
Ask about monopoly availability in your district.
Related articles
third-party pharma manufacturing cost in India
Third-Party Pharma Manufacturing Cost in India: A Complete Guide
Third-Party Pharma Manufacturing Cost in India | Dokcare Lifesciences The pharmaceutical industry in India has experienced exponential growth over the...
Read MoreThird-Party Manufacturing vs Loan Licence
Third-Party Manufacturing vs Loan Licence: Which Pharma Manufacturing Model Is Right for Your Business?
Third-Party Manufacturing vs Loan Licence | Dokcare Lifesciences Selecting the most suitable production strategy is one of the most critical decisions...
Read MoreRevised Schedule M
Revised Schedule M: A Comprehensive Guide to Compliance and Quality Excellence in Pharmaceutical Manufacturing
Revised Schedule M | Dokcare Lifesciences The Indian pharmaceutical industry is undergoing one of its most transformative regulatory evolutions in rec...
Read More